Evidence map›Paper›PMID 30465827›Full record

ReviewCellular signalling2019

How do chemokines navigate neutrophils to the target site: Dissecting the structural mechanisms and signaling pathways.

Krishna Rajarathnam, Michael Schnoor, Ricardo M Richardson, Sudarshan Rajagopal

Open access · greenAbstract readReview
In one paragraph

Review in Cellular signalling, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 137 papers.

0numbers the graph read from it
0cells of the map it votes in
137citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

137 citing papers in PubMed, 240 citations in OpenAlex.

  1. Trial
  2. AdipocyteCells · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Case Report: NovelFrontiers in immunology · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. CXCR1 and CXCR2 display receptor bias for shared chemokine agonists.bioRxiv : the preprint server for biology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article

77 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Krishna RajarathnamDepartment of Biochemistry and Molecular Biology, Department of Microbiology and Immunology, Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USA. Electronic address: krrajara@utmb.edu.
Michael SchnoorDepartment for Molecular Biomedicine, Cinvestav-IPN, 07360 Mexico City, Mexico.
Ricardo M RichardsonJulius L. Chambers Biomedical/Biotechnology Research Institute, North Carolina Central University, Durham, NC 27707, USA.
Sudarshan RajagopalDepartment of Medicine (Cardiology), Duke University, Durham, NC, USA.
Duke University · USInstituto Politécnico Nacional · MXNorth Carolina Central University · USThe University of Texas Medical Branch at Galveston · US

Funding

Understanding Perceptions of HIV Risk, PrEP, and PrEP use among African American Women Attending an HBCUU54MD012392 · NIMHD · NORTH CAROLINA CENTRAL UNIVERSITY · PI Cherise Baldwin Harrington · 2017 to 2026
$38.1M
Therapeutic assessment of synthetic heparin sulfates in transplantation modelsP01HL107152 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI DESAI, UMESH RAMANLAL · 2011 to 2017
$15.8M
Targeting the MEKK2-ERK5 Signaling Node in Triple Negative Breast CancerU54CA156735 · NCI · NORTH CAROLINA CENTRAL UNIVERSITY · PI RICHARDSON, MICHELER RICARDO · 2010 to 2021
$13.0M
Biasing CXCR3 Signaling to Modulate the Inflammatory ResponseR01GM122798 · NIGMS · DUKE UNIVERSITY · PI RAJAGOPAL, SUDARSHAN · 2017 to 2025
$3.2M
Regulation of Chemokine Mediated Leukocyte FunctionsR01AI038910 · NIAID · NORTH CAROLINA CENTRAL UNIVERSITY · PI RICHARDSON, MICHELER RICARDO · 2002 to 2011
$2.3M
Engineered chemokines as therapeutics for bacterial infectionsR21AI135606 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI CHOPRA, ASHOK K, RAJARATHNAM, KRISHNA · 2018 to 2019
$499k
Chemokine Synergy and Neutrophil FunctionR21AI124681 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI RAJARATHNAM, KRISHNA · 2016 to 2017
$426k
REGULATION OF HUMAN INTERLEUKIN-8 RECEPTORSR29AI038910 · NIAID · DUKE UNIVERSITY · PI RICHARDSON, MICHELER RICARDO · 1996 to 2000
$107k
NCI NIH HHS U54 CA156735NHLBI NIH HHS P01 HL107152NIAID NIH HHS R01 AI038910NIAID NIH HHS R21 AI124681NIAID NIH HHS R21 AI135606NIAID NIH HHS R29 AI038910NIGMS NIH HHS R01 GM122798NIMHD NIH HHS U54 MD012392
6 · The paper itself

Abstract

Chemokines play crucial roles in combating microbial infection and initiating tissue repair by recruiting neutrophils in a timely and coordinated manner. In humans, no less than seven chemokines (CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8) and two receptors (CXCR1 and CXCR2) mediate neutrophil functions but in a context dependent manner. Neutrophil-activating chemokines reversibly exist as monomers and dimers, and their receptor binding triggers conformational changes that are coupled to G-protein and β-arrestin signaling pathways. G-protein signaling activates a variety of effectors including Ca

Indexed as

Chemokines, CXCNeutrophilsReceptors, CXCRAnimalsbeta-ArrestinsGTP-Binding ProteinsHumansMiceProtein BindingSignal Transductionbeta-ArrestinsChemokines, CXCGTP-Binding ProteinsReceptors, CXCR

Identifiers

PMID30465827
PMCPMC6664297
OpenAlexW2901815433

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.